1. Juvenile Idiopathic Arthritis: Diagnosis and Treatment

   • Gabriella Giancane
   • Alessandro Consolaro
   • Angelo Ravelli

   Review Open access 12 August 2016 Pages: 187 - 207

   

2. An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus

   • Amit Thakral
   • Marisa S. Klein-Gitelman

   Review Open access 30 September 2016 Pages: 209 - 219

   

3. Review of Osteosarcoma and Current Management

   • Ryan A. Durfee
   • Maryam Mohammed
   • Hue H. Luu

   Review Open access 19 October 2016 Pages: 221 - 243

   

4. Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe

   • Kunal Thakur
   • Anna Biberger
   • Mourad Farouk Rezk

   Original Research Open access 05 November 2016 Pages: 245 - 256

   

5. Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis

   • Peter Nash
   • Johan Vanhoof
   • Alfred Cividino

   Original Research Open access 18 August 2016 Pages: 257 - 270

   

6. First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study

   • Andreas Schwarting
   • Johann O. Schroeder
   • Heike Carnarius

   Original Research Open access 01 November 2016 Pages: 271 - 290

   

7. Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study

   • Alan Kivitz
   • Thomas Wallace
   • Margaret Michalska

   Original Research Open access 24 September 2016 Pages: 291 - 304

   

8. Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US

   • Vibeke Strand
   • Elaine Husni
   • Arijit Ganguli

   Original Research Open access 15 September 2016 Pages: 305 - 322

   

9. Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis

   • Keith A. Betts
   • Jenny Griffith
   • Arijit Ganguli

   Original Research Open access 25 July 2016 Pages: 323 - 336

   

10. Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources

    • Sharareh Monemi
    • Erhan Berber
    • Attila Pethoe-Schramm

    Original Research Open access 15 July 2016 Pages: 337 - 352

11. Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil

    • Marina Amaral de Ávila Machado
    • Felipe Ferre
    • Francisco de Assis Acurcio

    Original Research Open access 11 July 2016 Pages: 353 - 361

12. Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis

    • Philip Mease
    • Iain B. McInnes

    Erratum Open access 25 July 2016 Pages: 363 - 363

13. Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali^®) Versus Etanercept (Enbrel^®) - Findings from a Nurse Survey in Europe

    • Kunal Thakur
    • Anna Biberger
    • Mourad Farouk Rezk

    Erratum Open access 29 September 2016 Pages: 365 - 365